Saturday, December 02, 2006

Thailand Dilutes Merck’s Patent Monopoly

Government of Thailand has diluted Merck’s patent monopoly for antiretroviral drug --- Efavirenz, by triggering the provision for compulsory licensing which will allow Thailand to import generic efavirenz from India and also local production of the generic efavirenz. Compulsory license will be valid for five-years. However, Merck has shown disappointment over the issue.

No comments:

Post a Comment